Stories about the people, science and research of the Medical Research Council.
28 Jul 2020
At the end of 2019, Clinical Director, Professor Patrick Chinnery, shared the MRC’s plan to establish the Precision Medicine Accelerator, a new framework for clinical translational research funding. Here, Patrick updates us on the new Experimental Medicine Panel, the first stage in realising this vision.
Continue reading: Announcing the new Experimental Medicine Panel
28 Jul 2020
Europe PubMed Central (EPMC) has launched a new online grant finder tool to include a global dataset of COVID-19 projects. This new tool takes data from the UK Collaborative for Development Research (UKCDR) and Global Research Collaboration For Infectious Disease Preparedness (GloPID-R) COVID-19 Research Project Tracker, the most comprehensive international open dataset of pandemic-related research projects. MRC Director of Strategic Evaluation and Impact, Dr Ian Viney MBE, highlights how the tracking of research projects has accelerated and become more globally-connected in the pandemic, to better support the rapid pace of worldwide discovery and clinical research.
The UKCDR and GloPID-R COVID-19 Research Project Tracker provides an open dataset and user friendly analysis of thousands of pandemic-related research projects funded since the start of 2020, covering work in 100 countries. [...]
Continue reading: Mapping the COVID-19 research landscape: How tracking medical research funding has accelerated in the pandemic
24 Jul 2020
MRC Head of Operations, Sarah Collinge, shares some of her experiences about how funders are developing new ways to try and help researchers, like the UKRI COVID-19 Grant Extension Allocation.
Recent months as MRC Head of Funding Operations have been unprecedented and busy, grappling with urgently awarding new funding to research the coronavirus pandemic, while also thinking how to help our existing grant holders through and back to some form of normality. All with a toddler to keep entertained! I imagine our grant holders have similarly never known a time like it and we certainly aren’t close to returning to our normal working lives.
Continue reading: Helping MRC grant holders through a crisis
2 Jul 2020
Research into multiple long-term conditions, or multimorbidity, is a relatively new field and funders are actively working with various stakeholders to overcome the challenges as set out in the recently published cross-funder framework. The Strategic Priorities Fund (SPF) programme “Tackling multimorbidity at scale: Understanding disease clusters, determinants and biological pathways” is jointly funded by UK Research and Innovation – Medical Research Council (MRC) and the Department of Health and Social Care, through the National Institute for Health Research. After extensive round table discussions and workshops, this initiative was launched last year with the strategic objective to improve prevention, management and treatment of multimorbidity through building the UK’s capacity for transformative research in this area.
Continue reading: An ambitious programme for advancing research into multiple long-term conditions (multimorbidity)
3 Jun 2020
The current COVID-19 pandemic may have far-reaching effects on our mental health. Here our Executive Chair, Professor Fiona Watt, outlines how the MRC, and the researchers it supports, are tackling these important issues.
Continue reading: COVID-19 and Mental Health
18 Mar 2020
MRC Executive Chair, Professor Fiona Watt
As MRC Executive Chair, I would like to reassure you that we are well aware that there may be delays in your grant expenditure or that you may incur additional costs. We will deal with these as sympathetically and flexibly as possible. [...]
Continue reading: An update for MRC funded researchers regarding the coronavirus situation
6 Mar 2020
At least once a year, the MRC’s Council hits the road and heads to a different area of the UK to learn about MRC-funded research in the region. Council member Dr Roger Highfield explains the importance of MRC’s regional meetings, and shares his experience of the latest, held at the University of Manchester.
Decades ago, studies of Whitehall civil servants revealed that the lower you are in the social hierarchy, the higher your risk of illness and death. [...]
Continue reading: On the road: MRC regional meetings
7 Feb 2020
We’re launching a new initiative with a mission to unlock the potential of precision genetic medicines and speed up clinical developments. Professor Sir John Bell, Regius Professor of Medicine at Oxford University and Champion of the Life Sciences Industrial Strategy, tells us more about the Nucleic Acid Therapy Accelerator.
Today, I was delighted to join the launch event for the Nucleic Acid Therapy Accelerator (NATA), hosted by Professor Fiona Watt, the Executive Chair of the Medical Research Council, with interim NATA Director Professor Matthew Wood. [...]
Continue reading: Introducing NATA; the Nucleic Acid Therapy Accelerator
13 Jan 2020
Applications are now open to find 25 MRC researchers and technical experts for the next ‘I’m a Scientist Medical Research Zone’ in March 2020. Shonna Johnston, Flow Cytometry Facility Manager at the University of Edinburgh Queen’s Medical Research Institute, shares why more technicians should give it a go.
Image credit: Shonna Johnston
Last year, I took part in the I’m a Scientist MRC Festival Zone – an online competition giving school students the chance to connect with researchers and technical experts. The students challenged competitors in fast-paced live chats, asking anything they wanted, then voted for their favourite person to win a prize of £500 towards a public engagement activity of our choice. [...]
Continue reading: Connecting students with science
23 Dec 2019
Early in the new year, we’re launching a scheme to help speed up progress in translational research – and take research from the lab to the clinic faster. Here, our Clinical Director Professor Patrick Chinnery tells us more about the plans.
An independent report, published in September 2019, showed that our funding schemes for translational research – building on basic research to create new therapeutics and diagnostics – have been boosting the UK’s life sciences industry since we introduced them in 2008.
We commissioned the report to determine if these funding schemes had delivered innovation into health care and strengthened the return on investment from discovery research. We were pleased to find that the report showed the schemes had been successful. [...]
Continue reading: Establishing a new Precision Medicine Accelerator